tirzepatide e semaglutide vs. Semaglutide: Which Works Best? Tirzepatide vs Semaglutide: What You

Clinical Evidence: Retatrutide's Impressive Results In a recent phase 2 trial for obesity, retatrutide demonstrated remarkable efficacy: Up to 24.2% weight loss at 48 weeks with the highest dose, surpassing the weight loss seen with both semaglutide(15-17%)and tirzepatide (22.5%) at their respective highest doses

Explore the clinical evidence, why weight loss medicines trigger hair shedding, and when to see a GP

as well as the substantial impact of disease on longevity and quality of life, is a major concern in healthcare worldwide

Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026 $535 million in cash, cash equivalents and short-term investments as of April 30, 2026 Webcast to be held today at 8:30 a.m

A study of adults with diabetes suggests patients with obstructive sleep apnea derive a 20% greater mortality reduction from GLP-1 therapy than those without the sleep disorder.